Related Experiment Videos
[Light-chain nephropathy]
1II. Belgyógyászati Klinika, Szent-Györgyi Albert Orvostudományi Egyetem Pathologiai Intézet, Szeged.
Abstract:
The authors deal with the clinicopathology of the renal, alterations in light-chain disease in connection with 6 cases. The disease was recognized by the monotype (in 5 cases kappa, in 1 case lambda) immunoreactivity of the light-chain paraprotein deposited in the basal membranes of the renal tissue. Electron microscopic examinations proved the fine-granulated, electrodense character of the paraprotein. Multiple myeloma was found in 3 cases and plasma cell dyscrasia of non-tumorous characteristic in 3 cases in the background of the deposition. The renal involvement appeared clinically in the picture of proteinuria without nephrosis syndrome and in progressing azotemia. Chronic renal insufficiency developed during some months in 5 patients. Morphologically renal impairment manifested in interstitial fibrosis, tubular atrophy and ateriolar hyalinosis was seen. These were associated with different glomerular alterations, for instance in 3 cases with nodular glomerulosclerosis. In 1 patient with plasma cell dyscrasia of non-tumorous characteristic nodular glomerulosclerosis and semilunar formation was observed in 56% of the glomeruli. In an other patient with myeloma the simultaneous existence of cylinder nephropathy and light-chain nephropathy was demonstrated. Both observations are unusual phenomena in plasma cell dyscrasia.
Insights
Renal light-chain disease, identified by monoclonal light-chain paraprotein deposition, causes proteinuria and progressive kidney failure. Clinicopathological analysis reveals interstitial fibrosis, tubular atrophy, and glomerular changes in affected patients.
Area of Science:
- Nephrology
- Pathology
- Immunology
Context:
- Light-chain deposition disease (LCDD) is a rare condition affecting the kidneys.
- Pathological identification relies on monoclonal light-chain paraprotein deposits in renal tissue.
- Associated conditions include multiple myeloma and non-tumorous plasma cell dyscrasia.
Purpose:
- To investigate the clinicopathology of renal alterations in light-chain disease.
- To correlate clinical presentation with morphological findings in six cases.
- To characterize the nature of deposited paraprotein using electron microscopy.
Summary:
- Six cases of light-chain disease exhibited renal involvement characterized by proteinuria and azotemia.
- Monotypic light-chain paraprotein (kappa or lambda) was detected in renal basal membranes.
- Electron microscopy confirmed the fine-granulated, electrodense nature of the deposits.
- Morphological findings included interstitial fibrosis, tubular atrophy, arteriolar hyalinosis, and various glomerular alterations like nodular glomerulosclerosis.
- Chronic renal insufficiency developed rapidly in most patients.
Impact:
- This study enhances understanding of the clinicopathological spectrum of light-chain nephropathy.
- It highlights the association between specific paraprotein deposits and renal dysfunction.
- Findings contribute to the diagnosis and management of kidney disease in plasma cell disorders.